ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...

News reporter for Orlando Weekly, with a focus on state and local government, workers' rights, and housing issues. Previously ...

ARS, for its part, recently said it expects the product to launch in Germany first—as is ... which could make Neffy an attractive alternative on par with something like the overdose reversal nasal ...

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...